Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Pharmaceutical Companies Facing the Most Patent Expirations in 2016

Drug companies facing the most patent expirations in 2016

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are Takeda Pharms Usa, Santarus Inc, Celgene, Sanofi Aventis Us, Boehringer Ingelheim, Astrazeneca Pharms, Bayer Healthcare Llc, Abbvie, Allergan, and Glaxosmithkline.

Back to Pharmaceutical Patent Infographics

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc